Fluorometholone
Active ingredient · 6 therapeutic classes
Sold as FML
- Drug class
- Corticosteroids
- Availability
- See label
- Routes
- Ophthalmic
- Markets covered
- 2
- Products on record
- 3
Overview
Fluorometholone is an active pharmaceutical ingredient in the Corticosteroids group (C05AA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 2 | March 22, 2025 |
| GB United Kingdom | MHRA | 1 | September 27, 2024 |
CACanada· Health Canada
2 products
Uses
FML® (fluorometholone) is indicated for: • the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe. 1 Pediatrics (<18 years of age) No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric use.
2 Geriatrics (>65 years of age) No data are available to Health Canada; therefore, Health Canada has not authorized an indication for geriatric use.
How to take
GBUnited Kingdom· MHRA
1 product
Uses
For corticosteroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.
How to take
Drug interactions
Known interactions involving Fluorometholone. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]Health Canada (DPD) · 00247855 · revised March 22, 2025
- [2]MHRA (UK) · PL410420065 · revised September 27, 2024
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.